科学家开发血液测试,通过检测肿瘤DNA水平预测肺癌结果。 Scientists develop blood test that predicts lung cancer outcomes by detecting tumor DNA levels.

来自Francis Crick研究所和UCL的科学家开发了一项血液测试,检测循环肿瘤DNA(ctDNA),可以预测肺癌的结果。 Scientists from the Francis Crick Institute and UCL have developed a blood test that detects circulating tumor DNA (ctDNA), which can predict lung cancer outcomes. 这项名为NeXT Prison的测试发现,在手术前CtDNA水平较低的患者存活率较好,而且不太可能复发。 The test, called NeXT Personal, found that patients with lower ctDNA levels before surgery had better survival rates and were less likely to relapse. 这可能会导致更个性化的治疗计划和早期肺癌病人的更好结果。 This could lead to more personalized treatment plans and better outcomes for early-stage lung cancer patients.